# Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients

> **NCT02207153** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 217 (actual)

## Conditions studied

- Endstage Renal Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02207153
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2020-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02207153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02207153, "Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02207153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*